Inflammation of the Sacroiliac Joints and Spine and Structural Changes on Magnetic Resonance Imaging in Axial Spondyloarthritis: Five-Year Data From the DESIR Cohort.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
02 2022
Historique:
revised: 08 08 2020
received: 30 03 2020
accepted: 08 09 2020
pubmed: 17 9 2020
medline: 15 2 2022
entrez: 16 9 2020
Statut: ppublish

Résumé

To test the impact of inflammation on structural changes occurring in the sacroiliac (SI) joints and the spine detected on magnetic resonance imaging (MRI). Patients with early axial spondyloarthritis (SpA) from the Devenir des Spondylarthropathies Indifferérenciées Récentes (DESIR) cohort were included. MRIs of the SI joints (MRI-SI joints) and spine (MRI-spine), obtained at baseline, 2 years, and 5 years, were scored by 3 central readers. Inflammation and structural damage on MRI-SI joints and MRI-spine were defined by the agreement of ≥2 of 3 readers (binary outcomes) and by the average of 3 readers (continuous outcomes). The effect of inflammation (MRI-SI joints/MRI-spine) on damage (MRI-SI joints/MRI-spine, respectively) was evaluated in 2 models: 1) a baseline prediction model (the effect of baseline inflammation on damage assessed at 5 years); and 2) a longitudinal model (the effect of inflammation on structural damage assessed during a 5-year period). A total of 202 patients were included. Both the presence of bone marrow edema on MRI-SI joints and on MRI-spine at baseline were predictive of 5-year damage (≥3 fatty lesions) on MRI-SI joints (odds ratio [OR] 4.2 [95% confidence interval (95% CI) 2.4, 7.3]) and MRI-spine (OR 10.7 [95% CI 2.4, 49.0]), respectively, when adjusted for C-reactive protein level. The association was also confirmed in longitudinal models (when adjusted for Ankylosing Spondylitis Disease Activity Score) both in the SI joints (OR 5.1 [95% CI 2.7, 9.6]) and spine (OR 15.6 [95% CI 4.8, 50.3]). Analysis of other structural outcomes (i.e., erosions) on MRI-SI joints yielded similar results. In the spine, a significant association was found for fatty lesions but not for erosions and bone spurs, which occurred infrequently over time. We found a predictive and longitudinal association between inflammation detected on MRI and several types of structural damage detected on MRI in patients with early axial SpA, which adds to the evidence for a causal relationship.

Identifiants

pubmed: 32937029
doi: 10.1002/acr.24449
pmc: PMC9305528
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

243-250

Subventions

Organisme : Fundação para a Ciência e Tecnologia
ID : SFRH/BD/108246/2015
Organisme : Pfizer
ID : Unrestricted grant

Informations de copyright

© 2020 The Authors. Arthritis Care & Research published by Wiley Periodicals LLC on behalf of American College of Rheumatology.

Références

RMD Open. 2020 Feb;6(1):
pubmed: 32396521
Arthritis Rheum. 2005 Aug 15;53(4):502-9
pubmed: 16082639
Ann Rheum Dis. 2011 Aug;70(8):1369-74
pubmed: 21622969
Joint Bone Spine. 2015 Oct;82(5):345-51
pubmed: 26190454
Arthritis Res Ther. 2019 Nov 6;21(1):225
pubmed: 31694713
Clin Rheumatol. 2017 Jul;36(7):1551-1559
pubmed: 28536822
Arthritis Rheum. 2010 Oct;62(10):3048-58
pubmed: 20496416
RMD Open. 2018 Jan 12;4(1):e000586
pubmed: 29479474
Ann Rheum Dis. 2012 Dec;71(12):1998-2001
pubmed: 22915622
Eur J Clin Invest. 2018 May;48(5):e12912
pubmed: 29438579
Ann Rheum Dis. 2003 Jun;62(6):519-25
pubmed: 12759287
Ann Rheum Dis. 2016 Jun;75(6):1262-3
pubmed: 26903442
Ann Rheum Dis. 2019 Nov;78(11):1550-1558
pubmed: 31422357
Nat Rev Rheumatol. 2019 Nov;15(11):657-672
pubmed: 31591500
Ann Rheum Dis. 2012 Mar;71(3):369-73
pubmed: 21979001
Arthritis Rheum. 2009 Mar;60(3):717-27
pubmed: 19248087
Ann Rheum Dis. 2017 Nov;76(11):1823-1828
pubmed: 28684556
Arthritis Rheum. 2009 Jan;60(1):93-102
pubmed: 19116919
Arthritis Rheum. 1984 Apr;27(4):361-8
pubmed: 6231933
Ann Rheum Dis. 2016 Dec;75(12):2114-2118
pubmed: 27125522
RMD Open. 2018 Mar 16;4(1):e000624
pubmed: 29556419
Arthritis Care Res (Hoboken). 2019 Dec;71(12):1678-1684
pubmed: 30354022
Ann Rheum Dis. 2012 Aug;71(8):1278-88
pubmed: 22586174
Arthritis Res Ther. 2008;10(5):R104
pubmed: 18761747
Rheumatology (Oxford). 2018 Nov 1;57(11):1991-2000
pubmed: 30053219
Arthritis Rheumatol. 2014 Sep;66(9):2403-11
pubmed: 24909765
Ann Rheum Dis. 2014 Aug;73(8):1455-61
pubmed: 24812292
RMD Open. 2016 Nov 11;2(2):e000303
pubmed: 27933207
Ann Rheum Dis. 2010 May;69(5):891-4
pubmed: 19666937
Ann Rheum Dis. 2016 Aug;75(8):1486-93
pubmed: 26462728
Ann Rheum Dis. 2009 Oct;68(10):1520-7
pubmed: 19454404
Arthritis Rheum. 2004 Aug;50(8):2622-32
pubmed: 15334477
Ann Rheum Dis. 2014 Oct;73(10):1819-25
pubmed: 23852807
RMD Open. 2019 Feb 26;5(1):e000848
pubmed: 30886736
Ann Rheum Dis. 2016 Nov;75(11):1958-1963
pubmed: 26768408
Arthritis Rheum. 2005 Oct 15;53(5):703-9
pubmed: 16208659
Ann Rheum Dis. 2015 Jan;74(1):52-9
pubmed: 23956249
Ann Rheum Dis. 2016 Jul;75(7):1308-14
pubmed: 26286018

Auteurs

Alexandre Sepriano (A)

Leiden University Medical Center, Leiden, The Netherlands, and NOVA Medical School, Universidade Nova de Lisboa, Lisbon, Portugal.

Sofia Ramiro (S)

Leiden University Medical Center, Leiden, and Zuyderland Medical Center, Heerlen, The Netherlands.

Robert Landewé (R)

Amsterdam University Medical Center, Amsterdam, and Zuyderland Medical Center, Heerlen, The Netherlands.

Anna Moltó (A)

Hôpital Cochin, Assistance Publique, Hôpitaux de Paris, Université de Paris, INSERM (U1153), CRESS, Paris, France.

Pascal Claudepierre (P)

Hôpital Henri-Mondor, Assistance Publique-Hôpitaux de Paris Créteil, Paris, France.

Daniel Wendling (D)

CHRU de Besançon, University Teaching Hospital, and Université de Franche-Comté, EA4266 EPILAB, Besançon, France.

Maxime Dougados (M)

Paris Descartes University, Hôpital Cochin, Assistance Publique, Hôpitaux de Paris, INSERM (U1153), and Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France.

Désirée van der Heijde (D)

Leiden University Medical Center, Leiden, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH